My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Opko Health, Inc. - Common Stock (NQ:OPK)

1.300 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EST, Nov 20, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Opko Health, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

OPKO Health to Participate in the 40th Annual J.P. Morgan Healthcare Conference

January 05, 2022

From OPKO Health, Inc.

Via Business Wire

Attention Biotech Investors: Mark Your Calendar For January PDUFA Dates ↗

December 31, 2021

Regulatory decisions by the U.S. Food and Drug Administration in December turned out to be mostly positive. Among the treatment options that were greenlighted in the month were...

Via Benzinga

Opko Health Posts Data From COVID-19 Trial With Its Kidney Disease Treatment ↗

December 23, 2021

OPKO Health Inc (NASDAQ: OPK) has announced preliminary topline results from its Phase 2 trial with Rayaldee to treat mild-to-moderate COVID-19. This study...

Via Benzinga

Bulls Find Silver Lining Into the Close ↗

December 20, 2021

While it isn't exactly a ringing endorsement that the market is heading higher, it is an indication that the Grinch hasn't entirely spoiled the fun.

Via Talk Markets

Earnings Scheduled For October 28, 2021 ↗

October 28, 2021

Companies Reporting Before The Bell • LendingTree (NASDAQ:TREE) is estimated to report quarterly earnings at $0.57 per share on revenue of $292.63 million. •...

Via Benzinga

Earnings Scheduled For July 29, 2021 ↗

July 29, 2021

Companies Reporting Before The Bell • Smith & Nephew (NYSE:SNN) is projected to report earnings for its second quarter. • Cohen & Co (AMEX:COHN) is...

Via Benzinga

63 Biggest Movers From Friday ↗

December 20, 2021

Gainers Spruce Biosciences, Inc. (NASDAQ: SPRB) jumped 102.8% to close at $5.03 on Friday after Oppenheimer initiated coverage on the stock with an Outperform rating and a $15...

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

December 17, 2021

Gainers Genfit (NASDAQ:GN...

Via Benzinga

28 Stocks Moving In Friday's Mid-Day Session ↗

December 17, 2021

Gainers Genfit SA (NASDAQ: GNFT) shares jumped 33.6% to $4.41 after the company, and Ipsen, announced an exclusive licensing agreement for elafibranor. X4 Pharmaceuticals, Inc...

Via Benzinga

OPKO Health Q3 Earnings Ahead Of Expectations ↗

October 29, 2021

OPKO Health Inc (NASDAQ: OPK) reported Q3 revenues were down 10% Y/Y to $385.8 million, beating the consensus of $302.27 million. Revenue from diagnostic services...

Via Benzinga

Opko Health (OPK) Q3 2021 Earnings Call Transcript ↗

October 29, 2021

OPK earnings call for the period ending September 30, 2021.

Via The Motley Fool

Topics Earnings

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

October 28, 2021

Gainers Bellerophon Therapeutics (NASDAQ:

Via Benzinga

This Growth Hormone Drug Could Be a Boost For Pfizer ↗

October 05, 2021

Pfizer and OPKO Health's human growth hormone drug, somatrogon, could be approved by the U.S. Food and Drug Administration next January.

Via The Motley Fool

Pfizer's Growth Hormone Candidate FDA Review Pushed By 3 Months ↗

September 27, 2021

Pfizer Inc's (NYSE: PFE) effort to defend its growth hormone franchise against a new, more convenient competitor has hit a snag. The FDA has pushed back...

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

September 24, 2021

Gainers eFFECTOR Therapeutics (NASDAQ:

Via Benzinga

Rite Aid, in Partnership with the U.S. Department of Health and Human Services, BioReference Laboratories and New York State, Announces ‘Back to School’ COVID-19 Testing Program

August 26, 2021

From Rite Aid Corporation

Via Business Wire

The Daily Biotech Pulse: VectivBio In M&A Mix, Sonnet Biotherapeutics Advances Candidate To Clinics, CEO Transitions At Galapagos, Talis Biomedical ↗

August 31, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 26) Agenus Inc. (NASDAQ: AGEN)...

Via Benzinga

Why Opko Health Shares Shriveled by Nearly 8% on Friday ↗

July 30, 2021

The coronavirus stock didn't impress with its Q2 results.

Via The Motley Fool

Opko Health (OPK) Q2 2021 Earnings Call Transcript ↗

July 30, 2021

OPK earnings call for the period ending June 30, 2021.

Via The Motley Fool

Topics Earnings

The Daily Biotech Pulse: Merck's Disappointing Q2, Atreca Falls On Data, FDA Nod For Viatris, Nuvalent, Icosavax IPOs ↗

July 29, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 28) AbbVie Inc. (NYSE: ABBV)...

Via Benzinga

The Week Ahead In Biotech (July 25-31): Big Pharma Earnings, Iterum FDA Decision, Alzheimer's Conference, IPOs and More ↗

July 25, 2021

Biotech stocks rebounded in the week ended July 23, thanks to the broader market strength. The sector also benefitted from the optimism that was set in motion by the solid start...

Via Benzinga

Why Bionano Genomics, Invitae, and Opko Health Stocks Sank This Week ↗

July 16, 2021

The market's pessimism about these diagnostics stocks appeared unrelated to company-specific news.

Via The Motley Fool

Analyzing OPKO Health's Unusual Options Activity ↗

July 15, 2021

OPKO Health (NASDAQ:OPK) shares experienced unusual options activity on Thursday. The stock price moved up to $3.56 following the option alert. Sentiment: BULLISH Option Type:...

Via Benzinga

OPKO Health, CAMP4 Therapeutics Ink Oligonucleotide Platform With Focus On Drug-Resistant Epilepsy ↗

July 12, 2021

OPKO Health Inc (NASDAQ: OPK) has entered into an exclusive worldwide agreement with privately-held CAMP4 Therapeutics Corporation (CAMP4) to develop,...

Via Benzinga

OPKO Health, Nicoya Therapeutics Ink Rayaldee Pact For Hyperparathyroidism In Greater China ↗

June 21, 2021

OPKO Health Inc's (NASDAQ: OPK) subsidiary EirGen Pharma has agreed to develop and commercialize Rayaldee to treat secondary hyperparathyroidism in...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For June 21, 2021 ↗

June 21, 2021

Upgrades B of A Securities upgraded the previous rating for Cimarex Energy Co (NYSE:

Via Benzinga

OPKO Health Offloads Fill and Finish Manufacturing Facility in Ireland To Horizon Therapeutics ↗

June 17, 2021

OPKO Health Inc's (NASDAQ: OPK) subsidiary, EirGen Pharma Ltd, has agreed to sell one of its facilities in Waterford, Ireland, to Horizon Therapeutics plc...

Via Benzinga

Cramer Shares His Thoughts On MP Materials, Nokia And More In 'Lightning Round' ↗

May 23, 2021

On CNBC's "Mad Money Lightning Round," Jim Cramer said he would pass on Opko Health Inc. (NASDAQ: OPK). BOSTON OMAHA Corp (NASDAQ: BOMN) is a hard pass, said Cramer...

Via Benzinga

10 Health Care Stocks Showing Unusual Options Activity In Today's Session ↗

May 14, 2021

This unusual options alert can help traders discover the next big trading opportunities. Traders will search for circumstances when the market estimation of an option diverges...

Via Benzinga

Opko Health (OPK) Q1 2021 Earnings Call Transcript ↗

April 28, 2021

OPK earnings call for the period ending March 31, 2021.

Via The Motley Fool

Topics Earnings

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.